Executive Officers:
1. Mary Anne Heino - Chief Executive Officer and Director (Principal Executive Officer)
Mary Anne Heino has been the Chief Executive Officer of Lantheus Holdings Inc. since .
2. Robert J. Marshall, Jr. - Chief Financial Officer and Treasurer (Principal Financial Officer)
Robert J. Marshall, Jr. has been serving as the Chief Financial Officer of Lantheus Holdings Inc. since .
3. Andrea Sabens - Chief Accounting Officer (Principal Accounting Officer)
Andrea Sabens has been designated as the Chief Accounting Officer of Lantheus Holdings Inc. since .
Board of Directors:
1. Brian Markison - Executive Chair of the Board of Directors
Brian Markison has been appointed as the Executive Chair of the Board of Directors since .
2. Gerard Ber - Director
Gerard Ber joined the board as a Director .
3. Minnie Baylor-Henry - Director
Minnie Baylor-Henry joined the board as a Director .
4. Samuel R. Leno - Director
Samuel R. Leno became a Director .
5. Julie H. McHugh - Director
Julie H. McHugh joined the board as a Director .
6. Dr. James H. Thrall - Director
Dr. James H. Thrall became a Director .
7. Heinz Ma Usli - Director
Heinz Ma Usli joined the board as a Director .
8. Gary J. Pruden - Director
Gary J. Pruden became a Director .,
Lantheus Holdings Inc currently has 1193 employees.
News about Lantheus Holdings Inc Key Personnel |
Lantheus Applauds CMS 2025 Payment Rule Enhancements for Diagnostic Radiopharmaceuticals: PYLARIFY Positioned for Continued SuccessLantheus Holdings, Inc. a key player in the radiopharmaceutical industry, has recently expressed its commendation for the Centers for Medicare and Medicaid Services (CMS) decision to enhance payment structures related to specialized diagnostic radiopharmaceuticals for the calendar year 2025. This adjustment, highlighted in the final rule for the Medicare Hospital Outpatient Prospective Payment System (OPPS), marks a significant step toward improving patient access to essential diagnostic services. Enhanced Payment Rates and Improved AccessCMS s updated payment rates, posted in A...
|
In a significant move for the healthcare landscape, Lantheus Holdings, Inc. has expressed its commendation for the Centers for Medicare and Medicaid Services (CMS) recent rule concerning the calendar year 2025 Medicare Hospital Outpatient Prospective Payment System (OPPS). The announcement, made on November 4, 2024, signals a pivotal recognition of specialized diagnostic radiopharmaceuticals, which are critical in diagnosing and managing various diseases effectively.The final rule aims to improve the payment structure for these specialized products, enabling healthcare facilities to provide better access to essential diagnostic services for patients. By refining the accuracy of payment amounts, this reform p...
|
